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Context: Maternal adiposity in pregnancy is associated with offspring adiposity and metabolic
dysfunction postnatally, including greater risk of nonalcoholic fatty liver disease (NAFLD). Recent
genetic analyses suggest a causal effect of greater maternal body mass index on offspring birth
weightandponderal index,but the relative rolesof theenvironment inuteroor later in life remains
unclear.
Objective:We sought to determine whether markers of infant adiposity (birth weight, umbilical
cord blood leptin, adiponectin, and lipids) were associatedwithmarkers of NAFLD in adolescence.
Design, Setting, andParticipants: Thiswas aUKprospective birth cohortwith 17 years of follow-up
with liver function tests (aspartate aminotransferase, alanine aminotransferase, gamma-glutam-
yltransferase) (n  1037 participants), and ultrasound scan assessed liver fat, volume, and sheer
velocity at age 17 (n  541 participants). Missing covariate data were imputed.
Main Outcomes: Ultrasound and biochemical measures of NAFLD were measured.
Results: Birth weight, cord blood leptin, and adiponectin were not associated with a diagnosis of
NAFLD. In adjusted analyses, 2 of 42 associations attained conventional 5% levels of significance.
Birth weight was positively associated with liver volume (1.0% greater per 100 g [95% confidence
interval 0.5%–2.0%]). Cord high-density lipoprotein-cholesterol was positively associated with
alanine aminotransferase (11.6% higher per 1 mmol/L [95% confidence interval 0.3, 23.4]); how-
ever, this association was primarily mediated via offspring adiposity.
Conclusions: In this extensive analysis, we found little evidence measurements of infant fat mass
and birth sizewere related to adolescentmarkers of NAFLD. The association between birthweight
and adolescent liver volume may indicate the contribution of greater organ size to birth weight
and tracking of organ size. (J Clin Endocrinol Metab 101: 4661–4668, 2016)
Nonalcoholic fatty liver disease (NAFLD) is one of themost common causes of chronic liver disease chil-
dren in the developed world (1). The identification of
NAFLD in children and adolescents led to the speculation
that intrauterine events may contribute to its early patho-
genesis (2, 3). Intrauterine growth restriction and low
birth weight have been associated with liver cirrhosis-re-
lated mortality (4) and markers of liver damage and func-
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tion in adults (5). Although the causal effect of the supply
of excess nutrients to the fetus, as observed in maternal
obesity and diabetes, on increasing birth weight and neo-
natal adiposity is clear (6, 7), the influence on long-term
liver function is lesswell defined.Mouseandprimatemod-
els of a maternal high-fat diet during pregnancy exhibit
offspring obesity and hepatic lipid accumulation (8, 9).
Increasing maternal body mass index (BMI) has also been
associated with increased neonatal liver fat deposition
(10). Long-term human studies are, however, less consis-
tent with birth weight positively associated with adverse
liver function or a diagnosis of NAFLD at age 17 years in
some (11) but not all studies (12).
These differences may reflect that assessments of the in-
trauterine contribution to the onset of metabolic disease in
the offspring have primarily used birth weight, which re-
flects both fetal fat and lean mass. Umbilical cord blood
leptin is now widely recognized as an accurate biomarker
for neonatal fat mass, with higher levels associated with
greater fat mass (13). Cord blood adiponectin is also posi-
tively associated with birth weight (14). In mouse studies,
overexpression of fetal adiponectin increased the size of fat
depots in early life, whereas adiponectin knockout fetuses
display lower bodyweight and lower fat content (15). In the
current study,we sought to examine the relationship of neo-
natal fat mass with blood and ultrasound markers of liver
health in adolescents.We used cord bloodmeasurements of
leptin and adiponectin as markers of neonatal fat and also
examined cord blood lipids with adolescent liver outcomes.
To make this a comprehensive assessment, we additionally
examined birth weight with later
outcomes. In comparison with ear-
lier studies, we were better able to
adjust for potential confounding
by maternal characteristics includ-
ing maternal pregnancy BMI, com-
plications of pregnancy, and
smoking during pregnancy.
Design and Methods
Study population
The Avon Longitudinal Study of
Parents and Children (ALSPAC) is a
prospective, population-based birth
cohort study (16, 17). Full details of
the study have been published previ-
ously,with the studyweb site contain-
ing details of all the data that are
available through a fully search-
able data dictionary (http://www.
bris.ac.uk/alspac/researchers/data-
access/data-dictionary/). Ethical approval was obtained
from the ALSPAC Law and Ethics Committee and from the
National Health Service local ethics committee.
A total of 14 541 women were initially enrolled and
cord blood samples were available for 5011 mother-off-
spring pairs. Details of all participants who attended the
17–18 follow-up clinic visits (n 5081) provided blood-
based indicators of liver function (n  3188) and partic-
ipated in the liver ultrasound substudy (USS) (n  1887)
have previously been reported in detail (18, 19).Adetailed
outline of the exclusion criteria for this analysis is given in
Figure 1, but notably we included participants in the cur-
rent study if 1) they had a cord blood sample and 2) they
attended the 17- to 18-year follow-up study and had
blood-based indicators of liver function (n  1037) or
participated in the substudy with liver ultrasound mea-
surement (n  541).
Cord blood assays
Cord blood samples were obtained at the time of de-
livery and spun in preparation for storage at80°C since
then. All cord samples were assayed at the University of
Glasgow. Cord leptin and adiponectin were measured us-
ing commercially available ELISA kits (quantikine human
leptin immunoassay; R&D Systems). Cord lipids (choles-
terol, triglycerides, high density lipoproteins (HDL-c)
were measured using a Roche Cobas C311 autoanalyzer
using enzymatic reagents for lipid determination. Non-
high-density lipoprotein (Non-HDL-c) was calculated as
Figure 1. Cohort flow for this analysis.
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total cholesterol minusHDL-c. Analysis of the cord blood
was completed within a maximum of three freeze-thaw
cycles and remained at80°C in between. The interassay
coefficients of variability were 9.5% for leptin, 3.2% for
adiponectin, 4.0% for HDL-c, 3.0% for cholesterol, and
2.7% for triglycerides.
Assessment of liver outcomes
The protocol for USS assessment in ALSPAC has been
published previously (18). Briefly, upper abdominal USS
was completed by one of four trained sonographers using
a Siemens Acuson S2000 USS system. Echogenicity, our
marker of liver fat, was assessed during deep inspiration
and recorded as present, absent or uncertain according to
established protocols (20). This protocol has high levels of
sensitivity and specificity for moderate-severe NAFLD
(21, 22). A longitudinal image, in the sagittal plane, with
juxtaposition of the right lobe of the liver and the right
kidney, was viewed and echogenicity determined by com-
parison between the liver and kidney. Levels of agreement
in identifying echogenicity between the four sonographers
was 98% or greater, both immediately after training and
at 6-month intervals throughout data collection. Acoustic
radiation force impulse imaging of the right lobe of the
liver was used to measure liver stiffness (our main indica-
tor of liver stiffness), using standard protocols. Acoustic
radiation force impulse imaging, measured as shear ve-
locity in meters per second, was assessed six times with a
gap of at least 1 minute between each measurement. The
highest and lowest of these measurements were excluded,
and the Siemens Acuson S2000 system produced a mean
of the remaining four measurements. If this mean was
greater than 4 m/sec, a further six measurements were
taken from the left lobe. When both right and left lobe
valueswere available, the lowestmean of the two has been
used in analyses.
Fasting blood samples (minimum of 6 h) were imme-
diately spun and frozen at 80°C. Measurements were
assayed shortly (3–9mo) after sampleswere takenwith no
previous freeze-thaw cycles. All assays were completed in
the same laboratory at the University of Glasgow. alanine
aminotransferase (ALT), gamma-glutamyltransferase
(GGT), and aspartate aminotransferase (AST) were mea-
sured by automated analyzerwith enzymaticmethods. All
inter- and intraassay coefficients of variation for these
blood-based assays were less than 5%.
Assessment of covariates
Potential confounders included in this analysis are as
follows: maternal age; prepregnancy BMI; smoking sta-
tus (categorized as never smoked, smoked before but
not during pregnancy, and smoked during pregnancy);
parity; occupational social class; complications during
pregnancy (hypertensive or diabetic disorders); gesta-
tional age at birth;mode of delivery; and offspring’s sex.
Height, BMI, and fat mass at age 17.8 years were con-
sidered as potential mediators if any confounder ad-
justed associations were observed. Offspring weight
and height at the 17-year clinic assessment were mea-
sured using standard procedures in light clothing, with-
out shoes and used to calculate BMI. Weight was mea-
sured to the nearest 0.1 kg using Tanita scales. Height
was measured to the nearest 0.1 cm using a Harpenden
stadiometer. A narrow fan beam densitometer (Lunar
Prodigy; GEHealthcare Lunar Ltd)was used to perform
a whole-body duel-energy X-ray absorptiometry scan
from which fat mass was measured.
Statistical analyses
Offspring liver volume, fibrosis, and liver function
tests were log transformed to produce an approximately
normal distribution of residuals. Birth weight was ad-
justed for sex and gestational age using nonlinear re-
gression fitting a Gompertz curve.
Because human studies suggest that lower birth
weight and animal studies suggest that higher birth
weight is associated with a greater NAFLD risk, poten-
tial departure from linearity was explored by compar-
ing a model in which the exposure was entered in thirds
as two indicator variables and a model in which a linear
relationship was assumed across the thirds, using a like-
lihood ratio test. The multivariable linear and logistic
regression models were used to examine the associa-
tions between cord blood measures, birth weight and
fatty liver, liver volume, fibrosis, and liver function tests
at age 17 years.We tested for sex-exposure interactions,
and because there was no evidence to support these,
results are reported for male and female offspring
combined.
A series of multivariable regressionmodels were con-
structed to adjust for potential confounders and medi-
ators. The basic model (model 1) adjusted for offspring
sex and age at outcome assessment. In model 2 we ad-
ditionally adjusted for potential confounders: maternal
age, smoking in pregnancy, parity, occupational social
class, education, prepregnancy BMI, and alcohol con-
sumption in pregnancy. Our plan was to then examine
potential mediation by adjusting for each of offspring
BMI, fat mass, height, and height squared at age 17
years in any confounder-adjusted associations thatwere
not null.
There were small amounts of missing data on some
covariables included in the multivariable models. To
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deal with the missing data (any exposure, outcome or
confounder), 20 imputation data sets were generated by
chained equations (23), with measurements from the
15-year clinic informing imputation ofmissing values in
the 17-year clinic, respectively. We imputed up to 541
(all participants with a liver scan and paired cord sam-
ple) and up to 1037 (participants with liver function
tests [LFTs] and paired cord sample). The distributions
of observed and imputed variables were similar (Sup-
plemental Table 1). In the main paper, we present re-
sults from the imputed datasets and for comparison
present results from those with complete data (n 383–
Table 1. Characteristics of Those Who Had a Liver Scan (n  541) and/or Liver Function Tests (n  1037)
Performed at Age 17 Years and Percentage With Missing Data
Liver Scan Liver Function Tests
Median or %, n
Obs (IQR or n) n Obs
Missing,
%, n
Median or Obs,
%, n, IQR, or n n Obs
Missing,
%, n
Maternal characteristics
Age, y 29 (26, 32) 535 1.1 (6) 29 (26, 32) 1023 1.3 (14)
Smoking 525 3.0 (16) 77.1 (779) 1011 2.5 (26)
Never 74.9 (393) 7.6 (77)
Before, not during, pregnancy 9.5 (50) 15.3 (155)
During pregnancy 15.6 (82)
BMI 22.3 (20.5, 24.4) 479 11.5 (62) 22.0 (20.5, 24.1) 918 11.5 (120)
Parity 508 6.1 (33) 991 4.4 (46)
0 46.7 (237) 47.1 (467)
1 39.2 (199) 36.8 (365)
2 9.7 (49) 11.8 (117)
3 3.9 (20) 3.4 (34)
4 0.6 (3) 0.8 (8)
Social class 452 16.5 (89) 884 14.6 (153)
I (least disadvantaged) 6.9 (31) 8.0 (71)
II 38.5 (174) 38.4 (339)
III 40.3 (182) 39.5 (349)
IV 5.1 (23) 5.1 (45)
V 8.4 (38) 7.6 (67)
VI (most disadvantaged) 0.9 (4) 1.5 (13)
Education 518 4.3 (23) 994 4.1 (43)
Left school at age 16 y 56.6 (293) 53.3 (530)
A level 25.3 (131) 28.3 (281)
Degree 18.1 (94) 18.4 (183)
Alcohol 522 3.5 (19) 1009 2.7 (28)
None/1 glass/wk 43.5 (227) 43.0 (434)
1 glass/wk 46.4 (242) 45.9 (463)
1 glass/d 10.2 (53) 11.1 (112)
Offspring characteristics
Sex 541 0.0 (0) 1037 0.0 (0)
Male 39.7 (215) 46.4 (481)
Female 60.3 (326) 53.6 (556)
Birth weight, kg 3.5 (3.2, 3.8) 530 2.0 (11) 3.5 (3.2, 3.8) 1013 2.3 (24)
Cord leptin, pg/mL 6.2 (3.7, 11.9) 539 0.4 (2) 6.3 (3.6, 11.9) 1035 0.2 (2)
Cord adiponectin, g/mL 70.9 (51.0, 94.0) 533 1.5 (8) 73.5 (52.8, 95.0) 1026 1.1 (12)
Cord cholesterol, mmol/L 1.7 (1.5, 2.1) 529 2.2 (12) 1.7 (1.4, 2.0) 1021 1.6 (17)
Cord triglycerides, mmol/L 0.5 (0.4, 0.6) 524 3.1 (17) 0.5 (0.4, 0.6) 1016 2.1 (22)
Cord HDL-c, mmol/L 0.5 (0.4, 0.7) 518 4.3 (23) 0.5 (0.4, 0.7) 1005 3.1 (33)
Cord Non-HDL-c, mmol/L 1.2 (1.0, 1.5) 518 4.3 (2.3) 1.2 (0.9, 1.5) 1005 3.1 (33)
Liver volume, mL 1607.4 (1355.4, 1858.9) 541 0.0 (0)
Liver velocity, m/sec 1.2 (1.1, 1.3) 500 7.9 (41)
Diagnosis of fatty liver 1.8 (10) 371 31.4 (170)
GGT, U/L 31.4 (170) 16 (13, 21) 1037 0.0 (0)
ALT, U/L 31.4 (170) 14.8 (12, 19.2) 1037 0.0 (0)
AST, U/L 4.8 (26) 19.3 (16.6, 23.3) 1004 3.1 (33)
Fat mass, kg 17.4 (11.8, 23.9) 522 3.6 (19) 16.3 (10.6, 23.0) 1011 2.5 (26)
BMI, kg/m2 22.2 (20.2, 24.8) 522 3.6 (19) 22.1 (20.2, 24.7) 1011 2.5 (26)
Height 169.8 (163.8, 177.8) 171.4 (164.5, 178.9)
Diagnosis of obesity 31 (5.9) 51 (5.0)
Abbreviations: IQR, interquartile range; obs, observations. Data are median (IQR) or percentage of number of observations (n observations).
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813) in the Supplemental Material (Supplemental Ta-
bles 2 and 3).
All analyses were performed using StataMP version 12
(Stata Inc.).
Results
Table 1 summarizes the maternal and offspring charac-
teristics for those who attended the clinic at age 17 years
and had liver function tests and/or a liver ultrasound scan.
In most cases, the proportion of missing data for each
variable was less than 5%. Baseline characteristics for the
mothers and their young adult offspring were similar for
thosewho had just the bloodmeasures and thosewho had
USS.Of the 541whowere assessed by ultrasound, only 10
(1.8%) were categorized as having a fatty liver.
There was no strong evidence of associations between
birth weight, cord leptin, and lipids with ultrasound-di-
agnosed fatty liver (Table 2). Of 42 tests of associations of
exposures with blood and ultrasound markers of liver
health, two reached the conventional 5% significance
level (Table 3). Birthweightwas positively associatedwith
liver volume (1.0% greater per 100 g [95% confidence
interval [CI] 0.5, 2.0%]), and cord HDL-c was positively
associated with ALT (11.6%higher per 1mmol/L [95%
CI 0.3, 23.4]). There was no evidence of associations
between cord leptin or adiponectin with liver volume,
velocity, or LFTs in adolescence. There was also no
evidence of nonlinearity for birth weight or cord blood
measures with any of the blood- or ultrasound-based
liver outcomes.
To examine the effects of potential mediators, we in-
cludedoffspring fatmass, height (andheight squared), and
BMI at age 17 years in the fully adjusted models. The
association between birth weight and increased liver vol-
ume remained (1.0% greater per 100 g, 95% CI 0.1%,
1.0%), whereas the association of cord HDL-c and ALT
changed direction (1.0% lower per 1 mmol/L, 95% CI
2.0, 0.4).
Associations were similar when restricted to a com-
plete case, ie, including participants who had data on all
off the exposures, confounders, and outcomes (Supple-
mental Tables 2 and 3).
Discussion
In this study, we assessed prospective associations of birth
weight and cord blood measures of leptin, adiponectin,
and lipids with markers of adolescent liver structure and
function. Of a total of 42 confounder-adjusted tests, we
identified two that were significant at conventional 5%
levels: a positive association of birth weight with adoles-
cent liver volume and cord HDL-c with adolescent ALT.
Overall, these results do not suggest that birth weight,
birth fat (as assessed by cord leptin and adiponectin) or
cord lipids are associated with later offspring markers of
liver health when adjustment is made for maternal preg-
nancy characteristics that are likely to confound these
associations.
Birth weight has been associated both positively and
negatively with liver transaminases (5, 18, 24, 25) and a
greater risk of NAFLD, liver cirrhosis, and mortality (4,
24, 26). These nonconsistent findings may reflect the
problemswith using birthweight, which is a crudemarker
of the sum of antenatal and intrauterine exposures and
also fat and lean mass. We tried to extend these studies by
using cord blood adiponectin and leptin as surrogates of
neonatal fat mass.
Table 2. Association of Birth Weight and Cord Blood
Measures With NAFLD in Adolescence (Using Multiple
Imputation Data Sets) (n  541)
Outcome Age 17 y
Exposure
Diagnosis of Fatty Liver (Yes/No)
OR CI P Value
Cord leptin, per
10 pg/mL
Model 1 0.68 0.26, 1.73 .41
Model 2 0.62 0.23, 1.65 .33
Cord adiponectin,
per 10 g/mL
Model 1 0.85 0.70, 1.04 .13
Model 2 0.78 0.60, 1.01 .06
Cord cholesterol,
per 1 mmol/L
Model 1 0.81 0.36, 1.83 .62
Model 2 0.90 0.43, 1.87 .78
Cord triglycerides,
per 1 mmol/L
Model 1 0.74 0.09, 5.94 .78
Model 2 0.79 0.08, 8.20 .84
Cord HDL-c,
per 1 mmol/L
Model 1 0.51 0.04, 5.87 .58
Model 2 0.28 0.02, 3.78 .34
Non-HDL-c,
per 1 mmol/L
Model 1 0.82 0.33, 2.05 .67
Model 2 1.02 0.48, 2.15 .96
Birth weight,
per 100 ga
Model 1 1.00 0.88, 1.13 .98
Model 2 0.96 0.84, 1.10 .59
Adjustments for confounders included the following: model 1,
offspring sex and age; and model 2, offspring sex and age, maternal
age, smoking, parity, occupational social class, education,
prepregnancy BMI, and alcohol consumption during pregnancy.
a Birth weight adjusted for gestational age and sex.
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Adiponectin has consistently shown to be reduced in
children and adults with confirmed NAFLD (27–30).
Conversely, in anearlier publicationusing the samecohort
asusedhere, strongpositive associationsof leptin levels (as
well as fatmassandBMI)at age17yearswith liver fatwere
reported. Serum lipids are also known exhibit strong pos-
itive associations with adverse liver function in cross-sec-
tional analyses (30, 31). That we did not observe a
prospective longitudinal association of cord blood adi-
ponectin or leptin with markers of liver function in ado-
lescence suggests that their contribution at birth to the
pathogenesis of childhood NAFLD is limited. That cord
HDL-cwas positively associatedwithALT at age 17 years
may have been a chance finding. Collectively this suggests
that although leptin and adiponectin reflect neonatal
mass, disease in adolescence is primarily driven by child-
hood behavior rather than intrauterine exposures. Con-
sistent with this, cross-suckling experimental data suggest
that exposure to maternal obesity only via lactation more
aggressively programs a dysmetabolic and NAFLD phe-
notype than intrauterine exposure (8).
Whereas previous studies of birth weight with later
liver outcomes have been larger than this study, to our
knowledge this is the largest study to examine cord blood
measures in relation to subsequent liver outcomes, includ-
ing measurements assessed by USS. The prospective de-
sign, long duration of follow-up, detailed anthropometric
measures, and appropriate adjustment for maternal char-
acteristics that could confound the associations are sub-
stantive strengths. We do, however, acknowledge several
limitations. We used ultrasound to assess liver pathology
because it has been shown to detect moderate to severe
steatosis with similar accuracy as the gold standard liver
biopsywhile avoidinganunethical and invasiveprocedure
(21). For lesser degrees of hepatic fat mass, however, ul-
trasound may not be as sensitive a tool. The absence of
associations in this study may reflect this, particularly be-
cause a young adolescent population is more likely to ex-
hibit subtle changes in hepatic structure because the dis-
ease process itself may still be in its infancy. Further
assessment in later life may provide additional informa-
tion, by allowing time for liver abnormalities to fullyman-
ifest. Analyseswere limited to thosewith an available cord
blood sample and to those participants who attended the
17-year-old clinic; however, although we cannot directly
test this, it is unlikely that this should bias results.Multiple
imputationmethodswereused to account formissing con-
founder data,with a similar finding in thosewith complete
data on all confounders. The ALSPAC cohort is mainly of
white European origin, and as a result, this study may not
reflect other ethnicities that have previously been strongly
linked with hepatic dysfunction and elevated ALT levels
(32). Lastly, we acknowledge that multiple comparisons
were performed and our positive findings may have been
chance findings.
In animal models, insulin resistance, hyperketonemia,
and hepatic steatosis were all features of male but not
female offspring of obese mice (33), and there have been
inconsistent reports of gender-specific predispositions to
NAFLD. In the current study,most offspring participating
Table 3. Association of Birth Weight and Cord Blood Measures With Markers of Liver Health in Adolescence (Using
Multiple Imputation Data Sets) (n  541 for Liver Scans, n  1037 for LFTs)
LogLiver Volume, mL LogLiver Sheer Velocity, m/sec LogALT, U/L LogAST, U/L LogGGT, U/L
Outcome Age 17 y
Exposure model (1 and 2) % CI
P
Value % CI
P
Value % CI
P
Value % CI
P
Value % CI
P
Value
Cord leptin, per 10 pg/mL
Model 1 1.0 1.0, 3.0 .22 0.03 2.0, 1.0 .97 0.4 2.0, 3.0 .73 0.2 1.0, 2.0 .81 0.1 2.0, 2.0 .96
Model 2 0.3 2.0, 2.0 .79 1.0 2.0, 1.0 .46 0.6 3.0, 2.0 .61 0.03 2.0, 2.0 .97 0.5 3.0, 2.0 .66
Cord adiponectin, per 10 g/mL
Model 1 0.2 1.0, 1.0 .61 0.1 1.0, 1.0 .82 0.2 1.0, 1.0 .68 0.3 0.2, 1.0 .23 0.2 0.4, 1.0 .41
Model 2 0.1 1.0, 1.0 .79 0.04 0.6, 0. 6 .99 0.3 1.0, 1.0 .53 0.3 0.2, 0.8 .27 0.3 0.4, 0.9 .45
Cord cholesterol, per 1 mmol/L
Model 1 0.1 2.0, 2.0 .90 1.0 3.0, 1.0 .24 1.0 1.0, 4.1 .22 0.1 2.0, 1.0 .85 0.1 2.0, 2.0 .90
Model 2 0.02 2.0, 2.0 .98 1.0 3.0, 1.0 .38 1.0 1.0, 4.1 .25 0.2 2.0, 1.0 .82 0.03 2.0, 2.0 .97
Cord triglycerides, per 1 mmol/L
Model 1 0.4 5.8, 7.3 .91 2.0 7.7, 3.0 .45 2.0 3.9, 8.3 .53 0.01 4.9, 4.1 .76 2.0 6.8, 3.0 .49
Model 2 1.0 7.7, 5.8 .73 2.0 7.7, 3.0 .41 1.0 4.9, 8.3 .67 0.01 4.9, 3.0 .71 2.0 1.0, 4.1 .32
Cord HDL-c, per 1 mmol/L
Model 1 1.0 7.7, 9.4 .88 2.0 4.9, 9.4 .57 10.5 1.0, 22.1 .07 3.0 3.9, 10.5 .42 2.0 6.8, 11.6 .63
Model 2 2.0 5.8, 11.6 .60 4.0 3.0, 11.6 .22 11.6 0.3, 23.4 .04 3.0 3.9, 10.5 .40 3.0 5.8, 12.7 .47
Non-HDL-c, per 1 mmol/L
Model 1 0.1 2.0, 2.0 .97 2.0 3.0, 0.0 .13 1.0 1.0, 4.1 .36 0.4 2.0, 1.0 .69 0.3 3.0, 2.0 .81
Model 2 0.2 3.0, 2.0 .88 1.0 3.0, 0.6 .18 1.0 2.0, 4.1 .43 0.4 2.0, 2.0 .64 0.2 2.0, 2.0 .83
Birth weight, per 100 ga
Model 1 1.0 1.0, 2.0 .000 0.3 0.1, 1.0 .12 0.4 1.0, 0.2 .22 0.3 1.0, 0.1 .12 0.2 1.0, 0.3 .42
Model 2 1.0 0.3, 1.0 .001 0.1 0.3, 0.5 .69 1.0 1.0, 0.02 .06 0.4 1.0, 0.02 .06 0.4 1.0, 0.1 .15
Adjustments for confounders included the following: model 1, offspring sex and age; and model 2, offspring sex and age, maternal age, smoking,
parity, occupational social class, education, prepregnancy BMI, and alcohol consumption during pregnancy.
a Birth weight adjusted for gestational age and sex.
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in this study were female (60.3%), and this may account
for the low numberswith evidence ofNAFLD. Examining
offspring outcomes in adolescence may be too early in life
to identify thosewhogoon todevelopmetabolic disorders
such as NAFLD and type 2 diabetes. Our findings may
therefore underestimate the true prevalence of the disease
and account for the lack of associations in this study.Cord
blood sample degradation may have contributed to vari-
ability within the results, but leptin, adiponectin, and lip-
ids do appear to be stablewith long-term storage (34–37).
In the current study, there was no consistent evidence
that birth weight, neonatal adiposity, or cord lipids were
associated with liver dysfunction in adolescence. The as-
sociation of maternal adiposity to later offspring NAFLD
is likely to be a consequence of later environmental effects
or in utero effects not mediated via in utero adiposity.
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